Aug 13 |
Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
|
Jul 9 |
Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development Officer
|
May 31 |
Shareholders Will Likely Find Sutro Biopharma, Inc.'s (NASDAQ:STRO) CEO Compensation Acceptable
|
May 13 |
Sutro Biopharma GAAP EPS of -$0.95, revenue of $13M
|
May 13 |
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
|
May 13 |
Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
|
May 13 |
The past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitable
|
May 8 |
BofA starts Sutro at buy, cites ovarian cancer drug candidate
|
May 8 |
Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
|
May 1 |
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
|